文献速递神经肌肉病

DUX4蛋白的翻译后修饰影响FSHD细胞模型中的毒性功能

Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models.
PubMed 文献 · Ann Neurol · 2023-05-19

本研究利用FSHD体外模型,通过免疫沉淀和质谱鉴定DUX4蛋白的翻译后修饰(PTM),并用突变、蛋白质组学和生化实验在HEK293及人成肌细胞中表征这些修饰及其对DUX4毒性的影响。结果发现17个存在PTM的氨基酸,55个突变体中5个可保护细胞免受DUX4毒性并降低其反式激活FSHD生物标志物的能力,提示丝氨酸/苏氨酸磷酸化和/或抑制精氨酸甲基化可对抗DUX4毒性;蛋白激酶A(PKA)和蛋白精氨酸甲基转移酶(PRMT1)与DUX4相互作用。

要点

  • 在FSHD细胞模型中鉴定出DUX4蛋白17个氨基酸存在翻译后修饰。
  • 55个DUX4突变体中5个可保护细胞免受DUX4毒性并降低其反式激活FSHD生物标志物。
  • PKA和PRMT1与DUX4相互作用,提示其参与调控DUX4翻译后修饰。

核心结论

  • 结果支持DUX4受翻译后修饰调控,并为基于DUX4翻译后修饰及修饰酶的FSHD药物筛选奠定基础。

研究设计与样本

  • 研究采用FSHD体外模型,通过免疫沉淀DUX4蛋白并进行质谱鉴定翻译后修饰,利用突变、蛋白质组学和生化实验在HEK293及人成肌细胞系中表征DUX4翻译后修饰及潜在酶修饰因子。

主要发现

  • 鉴定出17个存在翻译后修饰的DUX4氨基酸,并生成55个旨在阻止或模拟翻译后修饰的DUX4突变体。
  • 5个突变体保护细胞免受DUX4介导的毒性,并降低DUX4反式激活FSHD生物标志物的能力。
  • 突变结果表明DUX4毒性可被丝氨酸/苏氨酸磷酸化和/或抑制精氨酸甲基化所对抗。
  • 发现多种酶可在体外修饰DUX4蛋白,并确认蛋白激酶A(PKA)和蛋白精氨酸甲基转移酶(PRMT1)与DUX4相互作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Facioscapulohumeral muscular dystrophy (FSHD) is caused by abnormal de-repression of the myotoxic transcription factor DUX4. Although the transcriptional targets of DUX4 are known, the regulation of DUX4 protein and the molecular consequences of this regulation are unclear. Here, we used in vitro models of FSHD to identify and characterize DUX4 post-translational modifications (PTMs) and their impact on the toxic function of DUX4. METHODS: We immunoprecipitated DUX4 protein and performed mass spectrometry to identify PTMs. We then characterized DUX4 PTMs and potential enzyme modifiers using mutagenesis, proteomics, and biochemical assays in HEK293 and human myoblast cell lines. RESULTS: We identified 17 DUX4 amino acids with PTMs, and generated 55 DUX4 mutants designed to prevent or mimic PTMs. Five mutants protected cells against DUX4-mediated toxicity and reduced the ability of DUX4 to transactivate FSHD biomarkers. These mutagenesis results suggested that DUX4 toxicity could be counteracted by serine/threonine phosphorylation and/or inhibition of arginine methylation. We therefore sought to identify modifying enzymes that could play a role in regulating DUX4 PTMs. We found several enzymes capable of modifying DUX4 protein in vitro, and confirmed that protein kinase A (PKA) and protein arginine methyltransferase (PRMT1) interact with DUX4. INTERPRETATION: These results support that DUX4 is regulated by PTMs and set a foundation for developing FSHD drug screens based mechanistically on DUX4 PTMs and modifying enzymes. ANN NEUROL 2023;94:398-413.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Knox RN, Eidahl JO, Wallace LM, et al. Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models. Ann Neurol. 2023. PMID: 37186119. doi:10.1002/ana.26668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。